Genex's June quarterly report shows encouraging positive operating cashflow and a strong solar revenue.

UniSuper, the award-winning over $120bn super fund, has appointed NorthStar Impact as a specialist external listed equities manager.

Botanix Pharmaceuticals has announced its BTX 1702 Phase 1b/2 clinical study on papulopustular rosacea has produced clinically meaningful data. 

Volpara Health Technologies (“Volpara”), which provides clinically validated software for the early detection of breast cancer, has been certified